Neuropeptide B-29 (Rat) (Non Brominated Form)

Neuropeptide B-29 (Rat) (Non Brominated Form)

0.5 mg
€300,00

Sie können eine Angebotsanfrage erstellen, nachdem Sie das Produkt in den Warenkorb gelegt haben.

Zu Produktinformationen springen
Neuropeptide B-29 (Rat) (Non Brominated Form)
  • Neuropeptide B-29 (Rat) (Non Brominated Form)
  • Neuropeptide B-29 (Rat) (Non Brominated Form)

Neuropeptide B-29 (Rat) (Non Brominated Form)

Produkt-ID: 4459

Trp- Tyr- Lys- Pro- Ala- Ala- Gly- Ser- His- His- Tyr- Ser- Val- Gly- Arg- Ala- Ala- Gly- Leu- Leu- Ser- Ser- Phe- His- Arg- Phe- Pro- Ser- Thr

€300,00
exkl. 19% MwSt.
Beschreibung

M.W. 3188.5

C147H211N43O38

Trp- Tyr- Lys- Pro- Ala- Ala- Gly- Ser- His- His- Tyr- Ser- Val- Gly- Arg- Ala- Ala- Gly- Leu- Leu- Ser- Ser- Phe- His- Arg- Phe- Pro- Ser- Thr

Neuropeptide B-29 is a ligand of NPBWR1 (GPR7)

Synthetic Product

The purity is guaranteed to be higher than 99% by HPLC

Referenzen:

1. R. Fujii, H. Yoshida, S. Fukusumi, Y. Habata, M. Hosoya, Y. Kawamata, T. Yano, S. Hinuma, C. Kitada, T. Asami, M. Mori, Y. Fujisawa and M. Fujino, J. Biol. Chem., 277, 34010 (2002) (Original) 2. H. Tanaka, T. Yoshida, N. Miyamoto, T. Motoike, H. Kurosu, K. Shibata, A. Yamanaka, S.C. Williams, J.A. Richardson, N. Tsujino, M.G. Garry, M.R. Lerner, D.S. King, B.F. O’Dowd, T. Sakurai and M. Yanagisawa, Proc. Natl. Acad. Sci. U.S.A, 100, 6251 (2003) (Pharmacol) 3. S. Aikawa, M. Ishii, M. Yanagisawa, Y. Sakakibara and T. Sakurai, Regul. Pept., 151, 147 (2008) (Pharmacol) 4. N. Hirashima, T. Tsunematsu, K. Ichiki, H. Tanaka, T.S. Kilduff and A. Yamanaka, Sleep,in press(Pharmacol)

You may also like